Noile-Immune Biotech Inc.
JPX: 4893.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Koji Tamada
- Employees
- 25
- Headquarters
- Minato, Japan
- IPO year
- 2023
- Market cap
- ¥6.6B
- Website
- https://www.noile-immune.com
Loading 4893…
Loading profile data…Frequently asked questions about 4893
What does Noile-Immune Biotech Inc. (4893.T) do?
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Where does 4893.T trade?
Noile-Immune Biotech Inc. (4893.T) trades on the Tokyo Stock Exchange.
What sector is 4893.T in?
Noile-Immune Biotech Inc. (4893.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Noile-Immune Biotech Inc.?
Koji Tamada is the chief executive officer of Noile-Immune Biotech Inc. (4893.T).
Where is Noile-Immune Biotech Inc. headquartered?
Noile-Immune Biotech Inc. is headquartered in Japan.
Does 4893.T pay a dividend?
Noile-Immune Biotech Inc. (4893.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4893.T go public?
Noile-Immune Biotech Inc. (4893.T) completed its initial public offering in 2023.